Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Proposed USPSTF guideline update: Advocating for earlier breast cancer screening at age 40

Hoag Memorial Hospital Presbyterian
Conditions
June 3, 2023
Share
Tweet
Share

Pop Quiz: At what age do medical experts recommend women of average risk for breast cancer begin receiving screening mammograms?

  1. 40
  2. 45
  3. 50
  4. All of the above.

If you answered “D,” you are correct. Confused? I don’t blame you. Medical societies and independent task forces do not agree on when to begin or end screening mammograms for women at average risk of developing breast cancer. This has led to confusion and frustration. But there is something that we as women can do about it.

The United States Preventive Services Task Force (USPSTF) recently proposed an update to its guidelines that would begin to close the yawning gap between recommendations. People have until June 6 to submit their comments about the proposal, and it is my hope that anyone who has been touched by breast cancer takes the time to review the guideline shift.

For context: The American Society of Breast Surgeons (ASBrS), the American Congress of Obstetricians and Gynecologists (ACOG), the American College of Radiology (ACR), and the National Comprehensive Cancer Network (NCCN) all recommend women should begin screening mammograms starting at age 40.

Meanwhile, the American Cancer Society’s guidelines call for women to begin annual screening at 45 and then get screened every two years starting at 55.

And in a highly controversial move in 2009, the USPSTF declared that women should not be screened until age 50, unless they are high-risk or opt for a more aggressive screening schedule.

These disparate recommendations have left women rudderless as they try to navigate their own well-being. Nationwide, breast cancer cases among women in their 40s rose 2 percent per year between 2015 and 2019.

Fortunately, the USPSTF recently proposed a guideline update that, if approved, would lower the recommended age to 40 for average-risk women.

This would bring all medical associations and societies in closer alignment. If approved, it would be the biggest breast imaging news in over a decade. A win for clarity and a win for women.

Why are the USPSTF’s recommendations so important? As the independent panel of primary care and prevention experts, the task force develops recommendations for primary care providers. The USPSTF influences how doctors act and what the recommendations they make to their patients.

After the 2009 recommendation, many primary care providers also stopped conducting clinical breast exams for women, meaning that women between the ages of 40 to 49 were neither physically examined nor routinely imaged for breast cancer until they were 50, unless they were at elevated risk for developing the disease or felt a lump and rushed to the doctor to get checked out.

Around 75 percent of breast cancers are diagnosed in patients who are not high-risk. This tells us that screening all women is important, and the earlier a woman’s cancer is diagnosed the better the outcome.

That is why I applaud this draft recommendation and urge people to support the draft language during the USPSTF’s comment period, which ends on June 6. You can review the recommendation and leave your comment here.

ADVERTISEMENT

While the shift does not create a completely aligned message, it is an important step. Next, I hope the medical community can come to a consensus on how often screening mammograms should be performed in average-risk women.

The USPSTF maintains in its new guideline recommendations that average-risk women should have a mammogram every two years, while the ASBrS, ACOG, ACR, and NCCN recommend annual screening. Make no mistake: Biennial screening does save lives. But extending annual screening to every other year principally increases the risk that the most aggressive, fastest-growing cancers are diagnosed too late.

In the meantime, if you have been touched by breast cancer, please consider voicing your support for this needed guidelines update.

This doesn’t completely end the confusion, but it’s an important step in the right direction. More than 60,000 women in the U.S. are diagnosed annually with breast cancer between the ages of 40-49. Earlier screening means more lives saved. Make your voice heard here.

January Lopez is a director of breast imaging, Hoag Memorial Hospital Presbyterian, Newport Beach, CA.

Prev

The rising threat of lung cancer in Asian American female nonsmokers

June 3, 2023 Kevin 2
…
Next

Master time management with 7 productivity strategies for optimal results

June 3, 2023 Kevin 0
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
The rising threat of lung cancer in Asian American female nonsmokers
Next Post >
Master time management with 7 productivity strategies for optimal results

ADVERTISEMENT

More by Hoag Memorial Hospital Presbyterian

  • Why male fertility needs to be part of every health conversation

    Hoag Memorial Hospital Presbyterian
  • Cancer treatment and sexual health: the conversation we need to have

    Hoag Memorial Hospital Presbyterian
  • How AI is transforming breast cancer detection: a game-changing tool for early diagnosis and personalized care

    Hoag Memorial Hospital Presbyterian

Related Posts

  • When breast cancer screening guidelines conflict: Some patients face real consequences

    Leda Dederich
  • Timely treatment decisions: the promise of surrogate markers

    Layla Parast, PhD
  • Is social media a friend or foe of science?

    Michael Joyce, MD
  • Cancer of the future: diagnosis, treatment, and impact on the health care system and patients

    Eugene Chan, MD
  • Questions about pharma pricing and marketing

    Martha Rosenberg
  • The health effects of structural racism

    Niran S. Al-Agba, MD

More in Conditions

  • Why peer support can save lives in high-pressure medical careers

    Maire Daugharty, MD
  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • What a childhood stroke taught me about the future of neurosurgery and the promise of vagus nerve stimulation

    William J. Bannon IV
  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • The quiet grief behind hospital walls

      Aaron Grubner, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • Bundled payments in Medicare: Will fixed pricing reshape surgery costs?

      AMA Committee on Economics and Quality in Medicine, Medical Student Section | Policy
    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • The quiet grief behind hospital walls

      Aaron Grubner, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • Bundled payments in Medicare: Will fixed pricing reshape surgery costs?

      AMA Committee on Economics and Quality in Medicine, Medical Student Section | Policy
    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...